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Purpose: Placebo effects are presumed to be based
on one’s expectations and previous experience with
regard to a speciﬁc treatment. The purpose of this
study was to investigate the role of the speciﬁcity and
valence of memories and expectations with regard to
itch in experimentally induced placebo and nocebo
itch responses. It was expected that cognitive schemas
with more general and more negative memories and
expectations with regard to itch contribute to less
placebo itch responding.
Methods: Validated memory tasks (ie, the Autobio-
graphical Memory Test and the Self-referential Endorse-
ment and Recall Task) and expectation tasks (ie, Future
Event Task and the Self-referential Endorsement and
Recall Task) were modiﬁed for physical symptoms,
including itch. Speciﬁcity and valence of memories and
expectations were assessed prior to a placebo experi-
ment in which expectations regarding electrical itch
stimuli were induced in healthy participants.
Findings: Participants who were more speciﬁc in
their memories regarding itch and who had lesser
negative itch-related expectations for the future were
more likely to be placebo itch responders. There were
no signiﬁcant differences in effects between the nocebo
responders and nonresponders.
Implications: The adapted tasks for assessing
cognitive (memory and expectations) schemas on
itch seem promising in explaining interindividual502differences in placebo itch responding. Future research
should investigate whether similar mechanisms apply
to patients with chronic itch. This knowledge can be
used for identifying patients who will beneﬁt most
from the placebo component of a treatment. (Clin
Ther. 2017;39:502–512) & 2017 The Authors. Pub-
lished by Elsevier HS Journals, Inc.
Key words: autobiographical memory, cognitive
bias, future expectations, itch, placebo effect.INTRODUCTION
Placebo and nocebo effects are known to contribute to
overall treatment outcomes in various conditions and
symptoms (eg, pain, itch).1 Whereas it is known that
speciﬁc learning mechanisms (eg, conditioning) in
general can result in placebo and nocebo effects,
placebo and nocebo responses vary tremendously
among individuals.2,3 In both experimental and clinical
studies, individuals’ placebo or nocebo responses have
been shown to range from no effect to profound changes
in symptoms or disease outcomes.4,5 Several studies haveVolume 39 Number 3
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remains a challenge.6 Although the respective literature
is still limited and inconsistent,6 certain traits have been
proposed to contribute to placebo and nocebo
responding, such as psychological traits, including
optimism, neuroticism, or catastrophizing7–9; genetic
predispositions10; and cognitive factors, including
cognitive schemas (ie, mental structure in which
thoughts, information, and their inter-relationships
are categorized) of memory about the past and expect-
ations about the future.11
Assessments of cognitive schemas of memories and
expectations have shown that dimensions of speciﬁcity
and valence of memories and expectations are of
particular importance. With regard to speciﬁcity of
memories and expectations, overgeneral autobiograph-
ical memory, deﬁned as difﬁculty in retrieving speciﬁc
autobiographical memories, has been shown to be
related to depression and trauma-related psychopathol-
ogy12 and difﬁculties with social problem solving13 but
speciﬁcity of autobiographical memory has never been
investigated with regard to placebo and nocebo
responses. With regard to valence of memories and
expectations, positive previous experiences and positive
expectations regarding a particular treatment are related
to greater placebo responding, and negative previous
experiences and negative expectations are related to
greater nocebo responding.14–16 Furthermore, prior
stimulus history can have an inﬂuence on placebo
response.17,18 For example, results from a study by Geers
et al17 showed that previous experience with a pain
stimulus (cold pressor task) in daily life (pain trough
contact with cold water) reduced the effectiveness of
placebo analgesic expectation.
In the current study we sought to determine
whether speciﬁcity and valence of memories and
expectations are associated with placebo and nocebo
itch responses. To answer this question, speciﬁcity and
valence of participants’ memories and expectations
regarding itch were assessed prior to a placebo and
nocebo itch experiment in which expectations were
induced by conditioning and verbal-suggestion proce-
dures (see Bartels et al16). Both speciﬁcity and valence
of memories and expectations were assessed with
validated tasks modiﬁed for itch by our research
group. We expected that, in particular, participants
with more speciﬁc and more positive memories and
expectations would show greater placebo responses,
while participants with less speciﬁc and more negativeMarch 2017memories and expectations would be more likely to
show nocebo responses. Furthermore, it was explored
whether speciﬁcity and valence of itch-related memo-
ries were related to speciﬁcity and valence of itch-
related expectations, respectively.PATIENTS AND METHODS
Data were obtained in a single study, from which
outcomes on the induction of placebo and nocebo
effects on itch by different expectation inductions have
been reported previously.16 The present study focused
on the inﬂuence of individual cognitive schemas on
placebo and nocebo itch responses. The methods (and
data) concerning the cognitive schemas have not been
described in the previous study. The methods con-
cerning the induction of placebo and nocebo effects,
and general preparatory steps, have previously been
described16 and are brieﬂy summarized here.
Ethics Statement
The study protocol was approved by a regional
medical ethics committee (CMO Arnhem-Nijmegen,
Nijmegen, the Netherlands) and follows the principles
stated in the Declaration of Helsinki. All participants
provided written informed consent and were reim-
bursed for their participation.
Participants
Healthy volunteers aged Z18 years were recruited
via an online research participant system (Sona
Systems, Tallinn, Estonia) and at the Radboud Uni-
versity Nijmegen (Nijmegen, the Netherlands). Inclu-
sion criteria were age Z18 years and ﬂuency in the
Dutch language. Exclusion criteria were severe mor-
bidity (eg, skin disease, multiple sclerosis, diabetes
mellitus), psychiatric disorders (eg, depression), color
blindness, regular use of medication in the preceding
3 months, use of pacemaker, pregnancy, and current
or a history of chronic itch or pain.
Study Design
The study comprised 2 sessions in the laboratory,
separated byZ1 week. During session 1, participants’
cognitive schemas (ie, speciﬁcity and valence of
memories and expectations regarding itch-related,
pain-related, and standard events) were assessed.
Speciﬁcity of memories was assessed with the
Autobiographical Memory Test (AMT); speciﬁcity of503
Clinical Therapeuticsfuture expectations, with the Future Event Task
(FET); valence of memories and future expectations,
with the Self-referential Endorsement and Recall
Task (SER).
During session 2, placebo and nocebo effects of
electrically induced itch were assessed. Participants
were randomized to 1 of 4 groups in which they
received either: (1) verbal suggestion; (2) conditioning;
(3) a combination of verbal suggestion and condition-
ing to induce expectations for low, medium, and high
itch intensity (intervention groups); or (4) a control
procedure (control group) (see Bartels et al16).
General Procedures
Recruitment was conducted by an online research-
participant system (Sona Systems, Tallinn, Estonia)
and through ﬂyers posted at Radboud University.
Eligibility of potential participants was determined
by means of online self-report screening question-
naires, assessed by Sona Systems (Tallinn, Estonia).
Session 1
At the ﬁrst laboratory visit (session 1), written
informed consent was obtained, and baseline itch,
pain, and fatigue were assessed using numeric rating
scales (NRSs) ranging from 0.0 (no itch/pain/fatigue at
all) to 10.0 (worst itch/pain/fatigue ever experienced).
Subsequently, the adapted AMT, FET, and SER were
administered in a randomized order. Also their sub-
tasks (itch, pain, and traditional (with emotional cue
words)) were administered in a randomized order.
Tasks Assessing Cognitive Schemas
Autobiographical Memory Test
The AMT was used for assessing the speciﬁcity of
memories of participants regarding speciﬁc cue words.
Three different versions of the AMT were adminis-
tered in this study: the traditional version (AMT-t)19;
a version for itch developed by our research group
(AMT-i); and one for pain developed by our research
group (AMT-p). The AMT-i was the focus of
this study.
In all versions of the AMT, the cue words were
consecutively, but in randomized order, presented
verbally, and participants were asked to recall and
write down a memory in response to each cue word.20
Participants were instructed to write down an
autobiographical memory, that is, a personally
experienced event, that happened any time in the504past, but not on the day of or the day before the
administration of the instrument. The event could be
important or not. Participants were asked not to write
down the same event twice. In accordance with the
Minimal Instructions version of the AMT,21 which is
more sensitive for detecting reduced speciﬁcity of
autobiographical memory in nonclinical individuals
than is the standard version, participants were not
explicitly asked to come up with a speciﬁc memory
but were merely asked “Can you write down an event
that the word X reminds you of?”. No examples of
correct or incorrect responses were given and no
practice items were provided. Participants were given
60 seconds per cue word to write down a memory.
The AMT-t consisted of 6 positive and 6 negative
emotional cue words (eg, happy or sad)19
(see Supplemental Appendix 1 in the online version
at http://dx.doi.org/10.1016/j.clinthera.2017.02.004).
The AMT-i consisted of 9 itch-related cue words
(Table I). The instructions were identical to those of
the traditional AMT, but the participants were
explicitly asked to write down a memory concerning
itch. The AMT-p consisted of 9 pain-related cue
words (see Supplemental Appendix 1 in the online
version at http://dx.doi.org/10.1016/j.clinthera.2017.
02.004) and the participants were explicitly asked to
write down a memory concerning pain.
The cue words used for the AMT-i and AMT-p
(also the FET-i and FET-p; see subsequent text) had
been collected from the itch and pain questionnaires,
online patient panels, and input from a group of
volunteers with chronic itch and/or pain symptoms.
Subsequently, this large pool of words was scored by
5 independent raters on: (1) applicability to itch/pain
(applicable to itch, pain, or neither); (2) familiarity,
ranging from 0 (completely unfamiliar) to 5 (com-
pletely familiar); and (3) conceivability, ranging from
0 (completely not conceivable) to 5 (completely
conceivable). The 18 words that scored the highest
on the 3 scales for itch were used in the AMT-i and
FET-i, and the 18 words that scored the highest on
the 3 scales for pain were used in the AMT-p and
FET-p.
Future Event Task
The FET was used for assessing the speciﬁcity of
future expectations of participants regarding speciﬁc
cue words. Three different versions of the FET were
administered in this study: the traditional versionVolume 39 Number 3
Table I. Cue words of the itch versions of the
adapted Autobiographical Memory
Task (AMT-i) and the adapted Future
Event Task (FET-i).*
Task Cue Words
AMT-i Itch remedy (middel tegen jeuk)
Sunburn peeling (vervellen)
Rubbing (wrijven)
Mosquito bite (muggenbult)
Itchy spot (plek die jeukt)
Scratching (krabben)
Wool (wol)
Eczema (eczeem)
Rash (huiduitslag)
FET-i Dry skin (droge huid)
Scratch open (openkrabben)
Itchy (jeukend)
Nettle (brandnetel)
Bumps (bultjes)
Tickling (kriebelen)
Allergy (allergie)
Skin (huid)
Itch (Jeuk)
*Original cue words in Dutch are shown in parentheses.
D.J.P. Bartels et al.(FET-t)22; a version for itch developed by our research
group (FET-i); and one for pain developed by our
research group (FET-p). The FET-i was the focus of
this study.
In the 3 versions of the FET, the cue words were
consecutively, but in randomized order, presented
verbally, and participants were asked to write down
an expectation in response to each cue word. Partic-
ipants were instructed to write down an autobio-
graphical expectation, that is, an expectation of an
event that can be personally experienced, which can
happen at any time in the future, but not on the day of
or the day after the administration of the instrument.
This expectation could be important or not important.
Participants were instructed not to write down the
same event twice. Also in the 3 FET variations,
“minimal instructions” were used, that is, participants
were not explicitly asked to come up with a speciﬁc
expectation but were merely asked “Can you write
down an expectation that the word X makes youMarch 2017think of?” No examples of correct or incorrect
responses were given, and no practice items were
provided. Participants were given 60 seconds per cue
word to write down an expectation.
The FET-t consisted of 6 positive and 6 negative
emotional cue words (eg, happy or sad)22
(see Supplemental Appendix 1 in the online version
at http://dx.doi.org/10.1016/j.clinthera.2017.02.004).
FET-i and FET-p each included 9 cue words (see
Table I for FET-i and see Supplemental Appendix 1
in the online version at http://dx.doi.org/10.1016/j.
clinthera.2017.02.004 for FET-p). The instructions
were identical to those of the general FET, but the
participants were explicitly asked to write down
expectations concerning itch and pain.
Coding of AMT and FET
Once a participant completed a version of the AMT
or FET (itch, pain, traditional), they were instructed, in
line with the procedure used by Debeer et al,21 to assign
a code to each response according to the following
categories: 1 (speciﬁc memory/expectation), M (memory
of an event that occurred more than once/expectation
that will occur more than once), or 4 (memory/
expectation of an event lasting for 41 day), or to
leave the answer blank (no memory/expectation was
written down by the participant).
Afterward, the participants’ responses to the AMT and
FET were coded by a trained researcher using a method
corresponding to that of Debeer et al.21 Memories/
expectations were coded as speciﬁc (see “1” in
preceding paragraph) when they referred to a particular
event that occurred/will occur within the course of 1 day,
at a particular time and place (eg, “When I went to the
museum last month I wore a wool sweater which was
very itchy"). Nonspeciﬁc memories/expectations were
qualiﬁed as either extended (a memory/expectation of a
period lasting for41 day, eg, “Last week I wore a wool
sweater for a couple of days”; see “4” in preceding
paragraph), categoric (a memory/expectation that
summarizes a number or category of events, eg, “Every
time I wore a wool sweater when I was a kid it felt so
itchy”; see “M” in preceding paragraph), or semantic
associates (verbal association with the cue, eg, “Wool
sweaters usually itch”). Failure to provide a memory/
expectation was classiﬁed as an omission. Finally, a
category of nonresponses included all incomplete
responses and all responses on which the
instructions had not been followed (ie, events505
Table II. Itch cue words for the Self-referential Endorsement and Recall task adapted for itch and pain.*
Adjective Type Past Future
Itch-positive Acceptable (acceptabel) Brief (kortdurend)
Reduced (verminderd) Cooled (verkoeld)
Manageable (handelbaar) Improved (verbeterd)
Tolerable (verdraagbaar) Relieved (verlost)
Governable (beheersbaar) Calmed (gekalmeerd)
Overcome (overwonnen) Acceptable (aanvaardbaar)
Itch-negative Annoying (irritant) Uncontrollable (oncontroleerbaar)
Dominating (allesbeheersend) Untameable (onbedwingbaar)
Constraining (dwingend) Unbearable (ondraaglijk)
Maddening (gekmakend) Intense (intens)
Provoking (treiterend) Persistent (hardnekkig)
Tormenting (kwellend) Impelling (opjagend)
*Original cue words in Dutch are shown in parentheses.
Clinical Therapeuticsmentioned more than once, unrelated to itch/pain,
or that occurred on the day of, before, or after the
administration of the instrument).
In cases in which a response was not clear to the
researcher, the participant’s assigned code was used as
a guide, unless the researcher considered the answer to
be a semantic associate or nonresponse (which the
participant was not able to assign), in which case the
researcher decided between semantic associate or
nonresponse. If speciﬁc, categoric, or extended was
the most likely code according to the researcher and
this code matched the participant’s assigned code, this
code was used as the ﬁnal code. If a participant’s
assigned code was not one of the researcher’s possi-
bilities, another trained researcher performed the
coding, and the 2 codes were compared. If there was
disagreement between the 2 researchers, a third
trained researcher was consulted and a ﬁnal code
was decided on using majority voting. For analysis of
the AMT and FET data, the proportion of speciﬁc
memories/expectations relative to the total number of
memories/expectations was calculated for each partic-
ipant (eg, AMT-i ¼ [No. of speciﬁc responses]/9
– [No. of omissions þ No. of nonresponses]).21Self-referential Endorsement and Recall Task
Adapted for Itch and Pain
The SER23 was used for assessing valence of
memories and expectations of participants. The SER506was adapted by our research group for itch and pain
(SER-ip) and included 48 cue words (adjectives)
presented on a laptop computer. The task included
12 positive and 12 negative adjectives concerning itch,
12 positive and 12 negative adjectives concerning
pain, and 8 ﬁller items, administered in randomized
order. The cue words used in the SER-ip were
collected from itch and pain questionnaires, online
patient panels, and input from a group of volunteers
with chronic itch and/or pain complaints and several
researchers. Four researchers did the ﬁnal selection of
the words. The itch-related cue words were the focus
of this study (Table II); the pain-related cue words can
be found in Supplemental Appendix 2 in the online
version at http://dx.doi.org/10.1016/j.clinthera.2017.
02.004. Participants were asked to indicate for each
word separately, by clicking “yes” or “no” on the
computer screen, whether the word described their
experience of itch in the past, experience of pain in the
past, expectation of itch in the future, or expectation
of pain in the future. A practice trial with general
words that were not directly related to itch or pain
preceded the actual task to ensure that participants
understood the instructions.
Session 2
The procedures of the second laboratory visit
(session 2) have previously been described18 and are
summarized here.Volume 39 Number 3
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were induced by verbal suggestion, conditioning, or a
combination of both procedures, and compared with
those from a control group without expectation
induction. Itch was induced with an electrical stim-
ulator (Isolated Bipolar Constant Current Stimulator
DS5; Digitimer, Welwyn Garden City, United King-
dom) at a 50-Hz frequency with a pulse duration of
100 ųs and at continuously increasing current inten-
sity (0.05 mA/s) to a maximum of 5 mA. The intensity
of the stimulation for the low-, medium-, and high-
intensity stimuli used in the conditioning design was
individually determined.
In the learning phase, 18 itch stimuli were applied,
of which the intensities depended on the manipulation
from the experimental group. Each itch stimulus was
preceded by a colored cue (in total, 6 green, 6 yellow,
and 6 red cues) presented on a computer screen. In the
learning phase of the verbal suggestion group (n ¼
23), participants were told that different colored cues
indicated that the stimulus intensity would be altered:
“A green cue will signal a decrease in itch intensity; a
red cue, an increase; and a yellow cue, no change in
itch intensity.” Regardless of the color of the cue
displayed, all itch stimuli were applied at a medium
intensity. In the conditioning group (n ¼ 24), the
green, yellow, and red cues were repeatedly paired
with low, medium, and high itch stimulus intensities,
respectively. In the conditioning with verbal sugges-
tion group (n ¼ 23), the conditioning procedure and
the verbal suggestion procedure were combined. In the
control group (n ¼ 25), no expectations regarding the
itch stimuli were induced, and the cues were shown
with itch stimuli randomly applied at low, medium, or
high intensity. Subsequently, in the testing phase, 15
stimuli of medium intensity were applied in all groups
(preceded by, in total, 5 green, 5 yellow, and 5 red
cues), together with the verbal suggestion that corre-
sponded with the verbal suggestion—if any—given in
the learning phase (see Bartels et al16). For the purpose
of the study, that is, to identify possible placebo
responders, only the results from the 3 placebo and
nocebo induction groups (and not the control group)
were used for the analyses.
Statistical Analysis
All analyses were performed using SPSS version
22.0 (SPSS Inc. Chicago, Illinois). AMT-i and FET-i
data were available from 78 of 95 participants. DataMarch 2017from 17 participants were unavailable because we
started the experiment using the standard AMT and
FET instructions19 but noticed almost no variation in
participants’ responses (ie, almost all responses were
speciﬁc). Therefore, we switched to the Minimal
Instructions version, which for the AMT-t has been
shown to be more sensitive in detecting reduced
autobiographical memory speciﬁcity in nonclinical
individuals than the standard version.21 SER-ip data
from 1 participant were unavailable due to equipment
failure.
The proportion of speciﬁc answers on the AMT-i
and FET-i were calculated. Mean SER-ip scores on
endorsement of itch-related words from the 4 catego-
ries (positive/negative, past/future) were separately
calculated. Assumptions (eg, of normality) regarding
the FET-i and SER-ip statistical test results were
violated. Nonparametric tests were used because
transforming of data did not result in normal
distribution.
For placebo and nocebo responding, the means of
the NRS itch scores were calculated for the placebo
and nocebo effects in the testing phases of the different
groups in session 2. The nocebo effect was calculated
as the difference between the mean itch NRS scores
associated with the 5 red cues and the 5 yellow cues in
the testing phase, and the placebo effect was calcu-
lated as the difference between the mean itch NRS
scores associated with the 5 green cues and the 5
yellow cues in the testing phase (see Bartels et al16).
Subsequently, the median placebo and nocebo effect
values from the 3 experimental groups (verbal
suggestion, conditioning, and verbal suggestion with
conditioning) combined were calculated, and placebo
and nocebo responders were classiﬁed as being at or
above median, while the nonresponders fell into
the category of below median. This classiﬁcation
system, used separately for the placebo and nocebo
effects, created the median-split factor for use in the
analyses.
To exploratively investigate the association
between memories and expectations with regard
to speciﬁcity and valence, correlation between
the speciﬁcity of memories (AMT-i) and the specif-
icity of expectation (FET-i) was determined in
all participants, using the Spearman correlation
coefﬁcient. Likewise, correlation between the
valence (positive/negative) of memories and valence
of expectations regarding itch (SER-ip) was507
Table III. Proportions* of specific memories and expectations for the placebo and nocebo effect, as measured
using the adapted Autobiographical Memory Test for itch (AMT-i) and the adapted Future Event
Task for itch (FET-i). Data are given as mean (SD).
Task
Placebo† Nocebo†
All
Participants‡
Responders
(n ¼ 31)
Nonresponders
(n ¼ 26)
Responders
(n ¼ 31)
Nonresponders
(n ¼ 26)
AMT-i 0.33 (0.15) 0.24 (0.15) 0.30 (0.15) 0.27 (0.17) 0.29 (0.17)
FET-i 0.10 (0.15) 0.12 (0.17) 0.12 (0.16) 0.10 (0.16) 0.10 (0.15)
⁎Theoretical range, 01. n Values are based on median split.
†Includes participants in the different placebo and nocebo inductions/conditions (ie, the verbal suggestion, conditioning,
and conditioning with verbal suggestion groups; the control group was excluded from data analysis).
‡AMT-i, n ¼ 78; FET-i, n ¼ 77; includes the control group.
Clinical Therapeuticsdetermined in all participants, using the Spearman
correlation coefﬁcient.
To test the hypothesis that placebo responders (based
on median-split analysis) had more speciﬁc memories
and expectations regarding itch, while nocebo respond-
ers (based on median-split analysis) had less speciﬁc
memories and expectations regarding itch, 2 independ-
ent t tests (regarding the AMT-i) and 2 Mann-Whitney
U tests (regarding the FET-i) were performed. To test the
hypotheses that placebo responders had endorsed more
positive memories and expectations regarding itch and
that nocebo responders had endorsed more negative
memories and expectations regarding itch, 8 Mann-
Whitney U tests were performed. For all analyses, the
level of signiﬁcance was set at P o 0.05.RESULTS
Participants
All 95 participants were of Dutch nationality (a
mean [SD] age, 22.7 [3.2] years; 77% women). For
analysis of AMT and FET, data from 78 participants
were available (see Statistical Analysis section). This
population was not signiﬁcantly different from the
main sample with regard to age and sex.Correlations Between Memory and Expectations
for Itch
No signiﬁcant correlations between the proportion
of speciﬁc memories (AMT-i) and the proportion of
speciﬁc expectations (FET-i) for itch were found.508Signiﬁcant correlations were found between the
valence of memories and expectations for itch; the
positive and negative memories for itch were both
signiﬁcantly correlated with positive (rs ¼ 0.422; P o
0.001) and negative (rs ¼ 0.483; P o 0.001) expect-
ations, respectively, for itch. This ﬁnding suggests that
participants who endorsed more positive memories
also endorsed more positive expectations, while those
endorsing more negative memories also endorsed
more negative expectations.
Specificity of Itch Memories and Expectations in
Relation to the Placebo and Nocebo Effects
The mean (SD) proportions of speciﬁc memories
(AMT-i) and expectations (FET-i) for the placebo and
nocebo effects are shown in Table III. An independent
samples t test showed that the mean (SD) proportion
of speciﬁc memories generated in response to itch-
related cue words was signiﬁcantly greater in the
placebo responders than in the placebo nonresponders
(0.33 [0.15] vs 0.24 [0.15]; t[55] ¼ 2.32; P ¼ 0.024),
indicating that participants with more speciﬁc itch
memories responded more strongly to the placebo
itch induction. The difference between the nocebo
responders and nonresponders was not signiﬁcant
(t [55] ¼ 0.91; P ¼ 0.365). Mann-Whitney U test did not
show a signiﬁcant difference in FET-i speciﬁcity
between the placebo responders and nonresponders
(U ¼ 372,500, z ¼ .534, p ¼ .593) or between the
nocebo responders and nonresponders (U ¼ 351,000,
z ¼ .910, p ¼ .363).Volume 39 Number 3
Table IV. Valence of memories and expectations for the placebo and nocebo effects on the itch as measured
with the adapted Self-referential Endorsement and Recall task. Data are given as mean (SD)
number.
Type/Subtask
Placebo† Nocebo‡
All
Participants§
(n ¼ 94)
Responders
(n ¼ 37)
Nonresponders
(n ¼ 33)
Responders
(n ¼ 35)
Nonresponders
(n ¼ 35)
Positive
Memories 4.54 (1.79) 4.76 (1.35) 4.54 (1.52) 4.74 (1.67) 4.61 (1.53)
Expectations 3.46 (1.73) 3.30 (1.31) 3.54 (1.69) 3.23 (1.37) 3.23 (1.53)
Negative
Memories 2.84 (1.59) 2.73 (1.42) 2.82 (1.56) 2.74 (1.46) 2.73 (1.58)
Expectations 0.97 (1.48) 1.33 (1.11) 0.94 (1.14) 1.34 (1.47) 1.13 (1.33)
†Placebo responders and nonresponders, n ¼ 37 and 33, respectively, based on median split. Includes participants in the
different placebo and nocebo inductions/conditions (ie, the verbal suggestion, conditioning, and conditioning with verbal
suggestion groups; the control group was excluded from data analysis).
‡Nocebo responders and nonresponders, n ¼ 35 and 35, respectively, based on median split. Includes participants in the
different placebo and nocebo inductions/conditions (ie, the verbal suggestion, conditioning, and conditioning with verbal
suggestion groups; the control group was excluded from data analysis).
§Includes the control group.
D.J.P. Bartels et al.Valence of Itch Memories and Expectations in
Relation to the Placebo and Nocebo Effects
The mean (SD) values of the valence of memories
and expectations regarding itch, as measured with the
SER-ip, related to the placebo and nocebo effects are
shown in Table IV. A Mann-Whitney U test showed
signiﬁcantly fewer negative itch-related expected
events in the future in the placebo responders than
in the placebo nonresponders (0.97 [1.48] vs 1.33
[1.11]; U ¼ 450.50; z ¼ 1.992; P ¼ 0.046),
indicating that participants with less negative itch
expectations responded more strongly to the placebo
itch induction. No signiﬁcant differences were found
between placebo responders and nonresponders with
regard to itch-related negative memories (U ¼ 583.00;
z ¼ –0.330; P ¼ 0.742), positive memories (U ¼
603.00; z ¼ –0.092; P ¼ 0.927), or positive expect-
ations (U ¼ 588.00; z ¼ –0.270; P ¼ 0.788). In
nocebo responders and nonresponders, no signiﬁcant
differences were found with regard to itch-related
negative memories (U ¼ 581.50; z ¼ –0.371;
P ¼ 0.711), negative expectations (U ¼ 527.00;
z ¼ –1.063; P ¼ 0.288), positive memories
(U ¼ 537.00; z ¼ –0.926; P ¼ 0.355), or positive
expectations (U ¼ 544.50; z ¼ –0.813; P ¼ 0.416).March 2017DISCUSSION
The ﬁndings from the present study suggest that
healthy participants’ cognitive schemas regarding spe-
ciﬁcity and valence of memories and expectations for
itch are related to placebo responding on itch. More
speciﬁcally, when investigating the cognitive schemas
prior to the induction of placebo and nocebo effects,
the placebo responders displayed more speciﬁc mem-
ories of itch-related events and endorsed fewer neg-
ative itch-related expectations for the future than did
the placebo nonresponders. In nocebo responders, no
signiﬁcant results were found with regard to speciﬁcity
and valence of cognitive schemas. Speciﬁcity of mem-
ories did not seem to be associated with the speciﬁcity
of expectations, but the valence of memories and
expectations were signiﬁcantly correlated for both
negative and positive valenced cognitive schemas.
Overall, the ﬁndings from the present study suggest
for the ﬁrst time that cognitive memory and expect-
ations tasks may be explored as possible relevant
predictors of placebo responses.
The ﬁnding concerning speciﬁcity of memories and
expectations, that is, that placebo responders had
previously generated more speciﬁc itch-related memo-
ries than did nonresponders, is in line with ﬁndings509
Clinical Therapeuticsfrom studies on autobiographical memories in relation
to psychopathology that indicated that a generalized
autobiographic memory, that is, reduced speciﬁcity of
memories, is related to negative outcomes such as
depression and trauma-related psychopathology12 and
difﬁculties with problem solving.13 The tendency to be
more speciﬁc in memory consolidation might be
beneﬁcial for the integration of new information,
such as learning placebo expectations in the present
study. It has also been proposed that reduced auto-
biographical memory can result from preliminary
stopping of the search for a speciﬁc memory prior to
the retrieval of the speciﬁc memory, due to mecha-
nisms such as rumination, avoidance, or reduced
executive control.12 The imagination of future events
is sought to occur through the same hierarchical
memory system.24 Moreover, more speciﬁc memories
have been shown to be related to a better ability to
imagine the future22,25 and thus possibly also imagin-
ing expectations regarding a certain treatment. This
ﬁnding was however not supported by the associa-
tions between speciﬁcity of memories on itch and
speciﬁcity of expectations on itch, which were not
signiﬁcantly associated in our study. In contrast to
retrieving itch-related speciﬁc memories, participants
in our study experienced difﬁculties in coming up with
(speciﬁc) expectations for itch, as reﬂected by the
relatively low FET-i scores, which might also explain
the lack of the association between itch-related mem-
ories and expectations. Finally, no signiﬁcant differ-
ences in speciﬁcity of memories or expectations for
itch were found between nocebo responders and
nonresponders. This ﬁnding could be explained by
the fact that nocebo effects are easier to induce than
are placebo effects, for instance by only 1 verbal
suggestion,26 and may therefore be less sensitive to
previous experiences and resulting expectations
regarding itch.
The ﬁnding concerning valence of memories and
expectations, that is, that placebo responders had
endorsed fewer negative (but not more positive) itch-
related events in the future than did nonresponders, is in
line with those from the large body of research that
shows that expectations mediate placebo responses.1 It is
also consistent with ﬁndings from related studies
showing that, compared with healthy controls, patients
with chronic pain and depressed patients endorse more
negative illness-related words.23,27 Moreover, it extends
this knowledge by showing that not only particular510expectations regarding the (placebo) treatment, but also
itch-related expectations irrespective of a treatment, may
affect placebo itch responding. The link between these
generic itch memories and expectations is underlined by
the present ﬁndings of signiﬁcant associations between
endorsement of more positive and negative memories
and expectations, respectively. However, we did not ﬁnd
signiﬁcant differences in the endorsement of itch-related
events in the past between the placebo responders and
nonresponders. This ﬁnding is in contrast to those from
previous studies showing that previous experiences with
a certain treatment14–16 or previous experience with a
stimulus17 can alter placebo responding. An explanation
for this could be that the current tasks were conducted
in healthy participants whereby we had purposely
excluded people with any past (or current) experiences
with chronic itch. Furthermore, no signiﬁcant differences
were found between nocebo responders and non-
responders with regard to valence of memories and
expectations for itch, which may also be related to
nocebo effects being less sensitive to previous experi-
ences and resulting in expectations.
The present study had some limitations. First, partic-
ipants had difﬁculties to come up with future expect-
ations regarding itch on the FET. This difﬁculty may
have limited the variability in scores and could explain
the lack of ﬁndings with regard to this task. Second,
minimal instructions were used for the AMT and FET to
achieve more variability in the answers of healthy
participants. Although previous studies in healthy
participants have shown greater variability in speciﬁc
and general answers and a relationship to depressive
symptomatology,21,28 one cannot exclude that partici-
pants came up with more general responses because they
did not understand the task due to the limited instruc-
tions rather than due to participants’ generalized re-
trieval style. Finally, as the present study was conducted
in a nonclinical homogeneous sample, the conclusions
cannot be generalized to the general population or to
clinical samples, which should be assessed in future
research. Moreover, several studies regarding memory
speciﬁcity have shown that the mechanisms underlying
the retrieval of speciﬁc memories might differ between
patients and healthy participants.29,30 Therefore it is not
yet clear whether and how speciﬁcity and valence of
memories and expectations regarding itch affect learning
of placebo and nocebo itch responding in clinical
groups, and patients with chronic itch in particular,
which could be addressed in future studies.Volume 39 Number 3
D.J.P. Bartels et al.This research suggests a relationship between cog-
nitive schemas for memories and expectations regard-
ing itch and placebo responding on itch. It suggests
that investigating speciﬁcity and valence of memories
and expectations seems useful for obtaining insight
into the individual differences in placebo responses to
further identify possible placebo responders. In the
long term, these ﬁndings could be useful for identify-
ing patients who will beneﬁt most from the placebo
components of a treatment.ACKNOWLEDGMENTS
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See Appendix 1 and Appendix 2.Appendix 1. Cue words for the traditional
version of the AMT and FET.
AMT FET
Happy (gelukkig) Laughing (lachen)
Interest (belangstellend) Gift (cadeau)
Successful (succesvol) Relaxed (ontspannen)
Safe (veilig) Compliment (compliment)
Surprised (verrast) Enthusiastic (enthousiast)
Proud (trots) Helpful (behulpzaam)
Sad (verdrietig) Crying (huilen)
Angry (boos) (Being) late (Laat (zijn))
Clumsy (onhandig) Fight (ruzie)
Hurt (gekwetst) Failing (fallen)
Lonely (eenzaam) Nervous (zenuwachtig)
Guilty (schuldig) Disappointed (teleurgesteld)
Cue words of the traditional version of the
Autobiographical Memory Task (AMT-t) and the
Future Event Task (FET-t). The cue words translated to
English and the original cue words used in Dutch are
displayed.Appendix 2. Pain cue words for the SER.
Past Future
Pain Positive adjectives Tolerable (tolerabel) Bearable (draaglijk)
Decreased (afgenomen) Controllable (controleerbaar)
Manageable (hanteerbaar) Maintainable (houdbaar)
Temporary (voorbijgaand) Eased (verzacht)
Cured (genezen) Tamed (bedwongen)
Healed (geheeld) Eased (verlicht)
Pain Negative adjectives Overwhelming (overweldigend) Burdening (belastend)
Penetrating (doordringend) Merciless (genadeloos)
Untenable (onhoudbaar) Debilitating (slopend)
Nagging (zeurend) Heavy (hevig)
Ungovernable (onbeheersbaar) Continuous (aanhoudend)
Exhausting (afmattend) Disturbing (verontrustend)
Pain cue words of the Self-referential Endorsement and Recall task (SER) adapted for itch and pain. The cue words
translated to English and the original cue words used in Dutch are displayed.
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